Evidence map›Paper›PMID 41446239›Full record

ArticlebioRxiv : the preprint server for biology2025

Single cell and spatial characterization of the human pancreas reveals drivers of beta cell dysfunction in cystic fibrosis.

Hannah M Mummey, Sierra Corban, Jacinta Lucero, Rebecca L Melton, Madeleine Pittigher, Victoria C Johnston, Gail H Deutsch, Agnieszka D'Antonio-Chronowska, Allen Wang, Rebecca L Hull-Meichle and 1 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Hannah M MummeyBioinformatics and Systems Biology Program, University of California San Diego, La Jolla CA.
Sierra CorbanDepartment of Pediatrics, University of California San Diego, La Jolla CA, USA.
Jacinta LuceroCenter for Epigenomics, Department of Cellular and Molecular Medicine, University of California San Diego; La Jolla CA.
Rebecca L MeltonDepartment of Pediatrics, University of California San Diego, La Jolla CA, USA.
Madeleine PittigherBioinformatics and Systems Biology Program, University of California San Diego, La Jolla CA.
Victoria C JohnstonAlberta Diabetes Institute and Department of Cell Biology, University of Alberta, Edmonton, AB, Canada.
Gail H DeutschDepartment of Pathology, Seattle Children's Hospital and University of Washington, Seattle, Washington, United States.
Agnieszka D'Antonio-ChronowskaCenter for Epigenomics, Department of Cellular and Molecular Medicine, University of California San Diego; La Jolla CA.
Allen WangCenter for Epigenomics, Department of Cellular and Molecular Medicine, University of California San Diego; La Jolla CA.
Rebecca L Hull-MeichleAlberta Diabetes Institute and Department of Cell Biology, University of Alberta, Edmonton, AB, Canada.
Kyle J GaultonDepartment of Pediatrics, University of California San Diego, La Jolla CA, USA.

Funding

Translational Research CoreP30DK117469 · NIDDK · DARTMOUTH COLLEGE · PI DEBORAH A HOGAN · 2018 to 2026
$13.9M
Graduate Training Program in BioinformaticsT32GM139790 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAFNA, VINEET, GAASTERLAND, THERESA · 2021 to 2025
$2.1M
Mechanisms of Islet Failure in CFR01DK137209 · NIDDK · UNIVERSITY OF ALBERTA · PI REBECCA LUCY HULL-MEICHLE · 2024 to 2026
$1.3M
NIDDK NIH HHS P30 DK117469NIDDK NIH HHS R01 DK137209NIGMS NIH HHS T32 GM139790
6 · The paper itself

Abstract

Cystic fibrosis (CF) causes severely damaged pancreas morphology and results in high rates of cystic fibrosis-related diabetes (CFRD), but the cellular pathways and regulatory programs driving CFRD pathogenesis in the pancreas are not understood. In this study, we performed single cell multiomic and spatial profiling of 2.04M cells in the pancreas from 23 non-disease and CF donors and defined regulatory programs and tissue niches of specific cell types and sub-types in CF. A high-mucin sub-type of ductal cells had relatively preserved abundance, altered localization and up-regulated stress, secretion and pro-fibrotic activity in CF, and conventional ductal cells showed evidence for transition to the high-mucin state. Increased inflammatory and fibrotic pathway activity in CF was linked to closer proximity and crosstalk between immune and stellate cells in specific niches. Beta cells had extensive genomic changes in CF, including increased stress and insulin secretion-related processes, and these changes were broadly distinct from those in type 1 and type 2 diabetes. Islets in CF preferentially localized near large adipose tissue and collagen structures, and both areas were strongly linked to beta cell loss in CF due to signaling from adipocytes, macrophages, stellate, and high-mucin ductal cells. Overall, our results reveal cellular drivers of pancreatic dysfunction in CF and offer new in-roads to preserving beta cells in CFRD.

Identifiers

PMID41446239
PMCPMC12724667

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.